Filing Flows › Corvel (CRVL) › How it makes money
How Corvel (CRVL) makes money
Corvel (CRVL) made $267M of revenue in the second quarter fiscal 2027 (Q2 FY27), +11% from a year earlier. Patient Management Services brought in $168M (63%); Network Solutions Services brought in $99.5M (37%). Of every dollar of revenue, 27¢ was left as gross profit, 17¢ was left as operating profit, 13¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Patient Management Services | $168M | 62.7% | +5% | +11% |
| Network Solutions Services | $99.5M | 37.3% | -1% | +12% |
Where each dollar of revenue goes
| Line | Q2 FY27 | % of revenue |
|---|---|---|
| Revenue | $267M | 100.0% |
| Cost of revenue | $195M | 72.9% |
| Gross profit | $72.3M | 27.1% |
| Operating expenses | $26.5M | 9.9% |
| Operating profit | $45.8M | 17.2% |
| Income tax | $11.8M | 4.4% |
| Net earnings | $34.1M | 12.8% |
| Operating cash flow | $39.6M | 14.8% |
| Free cash flow | $29.3M | 11.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 FY27 | $267M | +12% |
| Q1 FY27 | $260M | +11% |
| Q4 FY26 | $249M | +7% |
| Q3 FY26 | $236M | +3% |
| Q2 FY26 | $240M | +7% |
| Q1 FY26 | $235M | +11% |
| Q4 FY25 | $232M | +12% |
From Corvel's 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Corvel make money?
Corvel (CRVL) made $267M of revenue in the second quarter fiscal 2027 (Q2 FY27), +11% from a year earlier. Patient Management Services brought in $168M (63%); Network Solutions Services brought in $99.5M (37%). Of every dollar of revenue, 27¢ was left as gross profit, 17¢ was left as operating profit, 13¢ was left as net earnings.
What is Corvel's biggest business?
Patient Management Services: $168M in the second quarter fiscal 2027, 63% of revenue, +11% from a year earlier.
What is Corvel's profit margin?
Net earnings were $34.1M, 12.8% of revenue, in the second quarter fiscal 2027; the operating margin was 17.2%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.